Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Elafibranor sulfoxide | 95.0% | 400.49 | C22H24O5S | 10 MG
SDP

Catalog No. 5000295462
Encompass_Preferred

Elafibranor sulfoxide is the sulfoxide metabolite of elafibranor supplied as a research-grade powder for in vitro and preclinical studies. It is intended for laboratory research use only and can be used to investigate PPAR-related pathways and metabolic disease models such as primary biliary cholangitis.

  • Chemical formula C22H24O5S, molecular weight 400.49.
  • Supplied as a powder; pack sizes include 10 MG.
  • Purity (NMR): 95.0%.
  • Target: PPAR; drug metabolite.
  • Storage: powder -20°C for 3 years, 4°C for 2 years; in solvent -80°C for 6 months, -20°C for 1 month.
  • Provided for research use only; not for human therapeutic use.

Catalog No. 50-002-95462 Supplier Medchemexpress LLC Supplier No. HY17651010MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Elafibranor sulfoxide is the sulfoxide metabolite of elafibranor supplied as a research-grade powder for in vitro and preclinical studies. It is intended for laboratory research use only and can be used to investigate PPAR-related pathways and metabolic disease models such as primary biliary cholangitis.

  • Chemical formula C22H24O5S, molecular weight 400.49.
  • Supplied as a powder; pack sizes include 10 MG.
  • Purity (NMR): 95.0%.
  • Target: PPAR; drug metabolite.
  • Storage: powder -20°C for 3 years, 4°C for 2 years; in solvent -80°C for 6 months, -20°C for 1 month.
  • Provided for research use only; not for human therapeutic use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.